About This Video
For more information on this and other stories, visit www.newsinfusion.com
Wayne, New Jersey, September 15, 2008 ? Bayer HealthCare Pharmaceuticals Inc. today announced that Betaseron (interferon beta-1b), its treatment for relapsing forms of multiple sclerosis (MS), will soon be available with a new 30-gauge needle, which will be the thinnest needle of any injectable disease-modifying therapy for people with MS. The new needle is as thin as the needle commonly used for insulin and pediatric injections.
?One of the barriers that many people with multiple sclerosis face in starting an MS treatment is injection anxiety," said Ludger Heeck, Vice President and General Manager, Specialty Medicine, Bayer HealthCare Pharmaceuticals Inc. "Betaseron is a safe and effective treatment for people with relapsing forms of MS, as well as those with the earliest signs of the disease. By introducing the thinnest needle of any injectable disease-modifying medication for MS, we are taking another important step in our commitment to continuously improve Betaseron and its use to help people start and stay on Betaseron long term, particularly those who may have resisted because of anxiety and concerns about injections.?
30
anxiety
autoinjector
barriers
bayer
betaject
betaseron
center
commitment
copaxone
for
gauge
healthcare
in
inc
injection
injections
jection
lite
medication
ms
multiple
needle
needles
offer
pharmaceuticals
rebif
sclerosis
south
symptoms
tampa
thin
thinnest
to
treatment
www.betaseron.com
www.betaseron.com/thinner
This website uses Adobe® Flash™ Player 9
Download Flash Now
If you are using Internet Explorer, you will need to restart your browser
after installing Flash.
Adobe and Flash are registered trademarks of Adobe Systems incorporated.
All rights reserved.